Veranova has a rich history spanning over 200 years, with a legacy that includes the development of more than 100 APIs and the introduction of the world’s first platinum-based cancer treatments. Veranova has consistently been at the forefront of scientific advancement.
Holding over 425 active patents in synthetic chemistry, Veranova’s expertise covers every aspect of the drug lifecycle, from intellectual property generation to manufacturing excellence. We partner with a wide range of pharmaceutical and biotechnology companies to fulfill our core mission: delivering life-changing therapeutics to patients in need.
